Radio and PodcastRadio and PodcastLive Radio & Podcasts
Perioperative Enortumab vedotin + Pembrolizumab artwork
Science & Medicine

Perioperative Enortumab vedotin + Pembrolizumab

OncoPharm by OncoPharmPod

Feb 19, 202600:16:30Science & Medicine

The EV-303 trial that led to the FDA approval of perioperative enfortumab vedotin + pembrolizumab in cisplatin-ineligible bladder cancer patients in now published in NEJM. We discuss the results and ponder potential futu...

About This Episode

Perioperative Enortumab vedotin + Pembrolizumab is an episode from OncoPharm by OncoPharmPod. The EV-303 trial that led to the FDA approval of perioperative enfortumab vedotin + pembrolizumab in cisplatin-ineligible bladder cancer patients...

Podcast

This episode belongs to OncoPharm.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Feb 19, 2026, 00:16:30 long, audio available.

Related Episodes

Continue listening to more episodes from OncoPharm.

Endurance Part 2

Jul 16, 2026 - 00:15:12

Did lenalidomide maintenance in multiple myeloma just get limited to 2 years? Endurance Trial, Part 2: Le...

Asco '26

Jun 11, 2026 - 00:25:38

ASCO 2026 is a wrap, and we needed an extra week to digest it all! Here the review list: 1. RASolute 302...

Pivekimab sunirine

May 28, 2026 - 00:13:49

Pivekimab sunirine, a novel CD-123 antibody drug conjugate is approved for Blastic Plasmacytoid Dendritic...

IMHOTEP, PJP, and more

May 14, 2026 - 00:09:59

This week's pod has lots of updates! IMHOTEP: Pre-operative doses of pembrolizumab lead to significant pC...